Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If you need an accessible version of this item please contact JSTOR User Support

Does Bleach Disinfection of Syringes Protect against Hepatitis C Infection among Young Adult Injection Drug Users?

Farzana Kapadia, David Vlahov, Don C. Des Jarlais, Steffanie A. Strathdee, Lawrence Ouellet, Peter Kerndt, Edward V. Morse E, Ian Williams and Richard S. Garfein
Epidemiology
Vol. 13, No. 6 (Nov., 2002), pp. 738-741
Stable URL: http://www.jstor.org/stable/3703492
Page Count: 4
  • More info
  • Cite this Item
If you need an accessible version of this item please contact JSTOR User Support
Does Bleach Disinfection of Syringes Protect against Hepatitis C Infection among Young Adult Injection Drug Users?
Preview not available

Abstract

Background. Hepatitis C virus (HCV) has emerged as a major public health problem among injection drug users. In this analysis we examine whether disinfection of syringes with bleach has a potentially protective effect on anti-HCV seroconversion. Methods. We conducted a nested case-control study comparing 78 anti-HCV seroconverters with 390 persistently anti-HCV seronegative injection drug users. These data come from the Second Collaborative Injection Drug Users Study, a prospective cohort study that recruited injection drug users from five U.S. cities between 1997 and 1999. We used conditional logistic regression to determine the effect of bleach disinfection of syringes on anti-HCV seroconversion. Results. Participants who reported using bleach all the time had an odds ratio (OR) for anti-HCV seroconversion of 0.35 (95% confidence interval = 0.08-1.62), whereas those reporting bleach use only some of the time had an odds ratio of 0.76 (0.21-2.70), when compared with those reporting no bleach use. Conclusions. These results suggest that bleach disinfection of syringes, although not a substitute for use of sterile needles or cessation of injection, may help to prevent HCV infection among injection drug users.

Page Thumbnails

  • Thumbnail: Page 
738
    738
  • Thumbnail: Page 
739
    739
  • Thumbnail: Page 
740
    740
  • Thumbnail: Page 
741
    741